aod9604 wada banned AOD 9604: Peptide Claims vs Clinical Reality AOD 9604 is marketed as a fat-metabolism peptide derived from a growth hormone fragment, often positioned as “HGH-like” without HGH's side effects. The clinical question 2019 WADA Prohibited List: Highlighted
2019 WADA Prohibited List: Highlighted Updates USADA Explanation of Key Changes on 2023 WADA Prohibited List AOD9604 does not influence the WADA hGH isoform immunoassay Orlovius 2013 Drug Testing and Analysis Wiley Online Library AOD 9604: Peptide Claims vs Clinical Reality, AOD 9604 is marketed as a fat metabolism peptide derived from a growth hormone fragment, often positioned as HGH like without HGHs side effects. The
Pay in 4 interest-free payments of $5.59 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


